Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
Resource Type
Abstract
Authors
Uy, Geoffrey L. ; Godwin, John ; Rettig, Michael P ; Vey, Norbert ; Foster, Matthew ; Arellano, Martha L. ; Rizzieri, David A. ; Topp, Max S. ; Huls, Gerwin ; Lowenberg, Bob ; Martinelli, Giovanni ; Paolini, Stefania ; Ciceri, Fabio ; Carrabba, Matteo Giovanni ; Ballesteros-Merino, Carmen ; Bifulco, Carlo B ; Lelièvre, Helene ; La Motte-Mohs, Ross ; Li, Daner ; Sun, Jichao ; Jacobs, Kenneth ; Spohn, Karen ; Lonsdale, Nadia ; Tran, Kathy ; Baughman, Jan ; Shannon, Michele ; Fox, Bernard ; Bonvini, Ezio ; Wigginton, Jon ; Davidson-Moncada, Jan ; DiPersio, John F
Source
In Blood 8 December 2017 130 Supplement 1:637-637
Subject
Language
ISSN
0006-4971